Vanguard Group Inc Allovir, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Allovir, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,647,010 shares of ALVR stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,647,010

Previous 2,647,010 -0.0%

Holding current value

$1.06 Million

Previous $1.91 Million 12.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.72 - $0.82 $198,319 - $225,864	-275,444 Reduced 9.43%	2,647,010 $1.91 Million
Q1 2024 May 10, 2024	SELL	$0.64 - $0.78 $10,336 - $12,597	-16,151 Reduced 0.55%	2,922,454 $2.22 Million
Q4 2023 Feb 14, 2024	BUY	$0.68 - $2.39 $127,213 - $447,118	187,079 Added 6.8%	2,938,605 $2 Million
Q3 2023 Nov 14, 2023	BUY	$2.15 - $3.64 $128,142 - $216,947	59,601 Added 2.21%	2,751,526 $5.92 Million
Q2 2023 Aug 14, 2023	SELL	$3.17 - $5.82 $890,408 - $1.63 Million	-280,886 Reduced 9.45%	2,691,925 $9.15 Million
Q1 2023 May 15, 2023	BUY	$3.94 - $7.05 $86,250 - $154,331	21,891 Added 0.74%	2,972,811 $11.7 Million
Q4 2022 Feb 10, 2023	BUY	$4.7 - $9.98 $186,684 - $396,405	39,720 Added 1.36%	2,950,920 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $3.56 Million - $7.59 Million	863,190 Added 42.15%	2,911,200 $23 Million
Q2 2022 Aug 12, 2022	SELL	$3.26 - $7.06 $2.05 Million - $4.45 Million	-630,291 Reduced 23.53%	2,048,010 $7.99 Million
Q1 2022 May 13, 2022	SELL	$6.75 - $13.52 $778,153 - $1.56 Million	-115,282 Reduced 4.13%	2,678,301 $18.1 Million
Q4 2021 Feb 14, 2022	SELL	$12.94 - $25.99 $16,446 - $33,033	-1,271 Reduced 0.05%	2,793,583 $36.1 Million
Q3 2021 Nov 12, 2021	BUY	$16.97 - $25.06 $7.51 Million - $11.1 Million	442,511 Added 18.81%	2,794,854 $70 Million
Q2 2021 Aug 13, 2021	BUY	$19.44 - $25.06 $45.7 Million - $58.9 Million	2,352,343 New	2,352,343 $46.4 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $37.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Allovir, Inc. Transaction History